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There is a growing trend towards public dissemination of proteomics data, which is 
facilitating the assessment, reuse, comparative analyses and extraction of new findings from 
published data1, 2. This process has been mainly driven by journal publication guidelines 
and funding agencies. However, there is a need for better integration of public repositories 
and coordinated sharing of all the pieces of information needed to represent a full mass 
spectrometry (MS)–based proteomics experiment. Your July 2009 editorial “Credit where 
credit is overdue”3 exposed the situation in the proteomics field, where full data disclosure is 
still not common practise. Olsen and Mann4 identified different levels of information in the 
typical experiment, starting from raw data and going through peptide identification and 
quantification, protein identifications and ratios and the resulting biological conclusions. All 
of these levels should be captured and properly annotated in public databases, using the 
existing MS proteomics repositories for the MS data (raw data, identification and 
quantification results) and metadata, whereas the resulting biological information should be 
integrated in protein knowledgebases, such as UniProt5. A recent editorial in Nature 
Methods6 again highlighted the need for a stable repository for raw MS proteomics data. In 
this Correspondence, we report on the first implementation of the ProteomeXchange 
consortium, an integrated framework for submission and dissemination of MS-based 
proteomics data.
Among the existing MS proteomics repositories with a broad target audience, the PRIDE 
(PRoteomics IDEntifications) database7 (European Bioinformatics Institute, EBI, 
Cambridge, UK; http://www.ebi.ac.uk/pride) and PeptideAtlas8 (Institute for Systems 
Biology, ISB, Seattle, USA; http://www.peptideatlas.org) are two of the most prominent. 
Both are mainly focused on tandem MS (MS/MS) data storage. Whereas PRIDE represents 
the information as originally analysed by the researcher (thus constituting a primary 
resource), data in PeptideAtlas are reprocessed through a common pipeline (the Trans-
Proteomic Pipeline) to provide a uniformly analyzed view on the data with a focus on low 
protein false discovery rates (constituting a secondary resource). In addition, ISB has set up 
the first repository for SRM data, PASSEL9 (PeptideAtlas SRM Experiment Library, http://
www.peptideatlas.org/passel/). There are other resources dedicated to storing MS 
proteomics data, each of them with different focuses and functionalities, for instance 
GPMDB (where data are reprocessed using the search engine X!Tandem)10. At a higher 
abstraction level, resources like UniProt and neXtProt are integrating proteomics results into 
a wider context of functional annotation from many different sources, including antibody-
based methods.
Although most of the proteomics resources mentioned have existed for a long time, they 
have acted independently with limited coordination of their activities. As a result, data 
providers were unclear to which repository they should submit their dataset, and in what 
form, with choices ranging from full raw data to highly processed identifications and 
quantifications. In addition, no repository could store both raw data and results. Similar 
issues arose for data consumers, who could not always find the data supporting a protein 
modification in UniProt, or know whether a particular dataset from PRIDE had been 
integrated into PeptideAtlas.
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The ProteomeXchange (PX) consortium (http://www.proteomexchange.org) was formed in 
2006 (ref. 11) to overcome these challenges, developing from a loose collaboration into an 
international consortium of major stakeholders in the domain, comprising, among others, 
primary (PRIDE, PASSEL) and secondary resources (PeptideAtlas, UniProt), proteomics 
bioinformaticians, investigators (including some involved in the HUPO Human Proteome 
Project), and representatives from journals regularly publishing proteomics data 
(Supplementary Notes, section 7). The aim of the ProteomeXchange consortium is to 
provide a common framework and infrastructure for the cooperation of proteomics resources 
by defining and implementing consistent, harmonised, user-friendly data deposition and 
exchange procedures among the major public proteomics repositories.
ProteomeXchange provides unified data submission for multiple MS data types and delivers 
different ‘views’ of the deposited data, such as the raw data suitable for reprocessing, the 
author-generated identifications and highly filtered composite results in resources like 
UniProt, all linked by a universal shared identifier. Authors are able to cite the resulting 
ProteomeXchange accession number for datasets reported in their publications. As such, a 
dataset (with appropriate metadata) is becoming publishable per se and can be tracked if 
used by various consumers in different publications.
Individual resources can join ProteomeXchange by implementing the ProteomeXchange 
data submission and dissemination guidelines, and metadata requirements. In the current 
version (http://www.proteomexchange.org/concept), the mandatory information comprises: 
(i) mass spectrometer output files (raw data, either in a binary format, or in a standard open 
format such as mzML); (ii) processed identification results (two submission modes are 
available, see below); and (iii) sufficient metadata to provide a suitable biological and 
technological background, including method information such as transition lists in the case 
of SRM data. Other types of information, such as peak list files (processed versions of mass 
spectra most often used in the identification process) and quantification results can also be 
provided.
Two main MS proteomics workflows are now fully supported: tandem MS and SRM data 
(Fig. 1 and Supplementary Fig. 1). PRIDE acts as the initial submission point for MS/MS 
data, whereas PASSEL is the initial submission point for SRM data. It is expected that in 
most cases, one ProteomeXchange dataset will correspond to data from one publication, and 
it will be clearly linked to it. However, this concept is flexible and a mechanism for 
grouping different ProteomeXchange datasets is also available, for example for large-scale 
collaborative studies. At present, two different submission modes are available for MS/MS 
data:
1. - ‘Complete submission’: this requires peptide and protein identification results to 
be fully supported and integrated in the receiving repository (PRIDE at present). 
The search engine output files (plus the associated spectra) must therefore first be 
converted to PRIDE XML or mzIdentML format (a process supported by several 
popular and user-friendly tools, Supplementary Notes, section 5). Complete 
submissions make the data fully available for querying, and thus maximise the 
potential for data re-use in MS. This in turn increases the visibility of the associated 
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publication. A DOI (Digital Object Identifier) is assigned to each dataset, allowing 
formalized credit to be given to submitters and their principal investigators, through 
a citation index, as proposed in your editorial3.
2. - ‘Partial submission’: For these submissions, peptide or protein identification 
results cannot be integrated in PRIDE because data converters and exporters to the 
supported formats are not yet available. In this case, search engine output files can 
be directly provided in their original format. Although partial submissions are 
searchable by their metadata, they are not fully searchable by results such as 
protein identifiers, and will not receive a DOI. However, partial submissions are 
important as they allow data from novel experimental approaches to be deposited 
into the ProteomeXchange resources, rather than having to reject these until the 
workflows have been mapped into a representation in PRIDE or another 
ProteomeXchange partner.
For the submission of MS/MS datasets, a stand-alone, open-source Java tool has been made 
available, the ‘ProteomeXchange submission tool’ (http://www.proteomexchange.org/
submission) (Supplementary Notes section 5, Supplementary Figs. 2–10). The tool allows 
interactive submission of small datasets as well as large- scale batch submissions.
For SRM datasets, a web form (http://www.peptideatlas.org/submit) can be used for 
submission to PASSEL. Similar to the guidelines stated above for MS/MS datasets, 
PASSEL submissions require mass spectrometer output files, study metadata, peptide 
reagents, analysis result files and the actual SRM transition lists, the information that drives 
the instrument data acquisition. Once datasets are submitted, they are checked by a curator 
and then loaded into the main PASSEL database, which facilitates interactive exploration of 
the data and results.
The submitted information and files can selectively be made available to journal editors and 
reviewers during manuscript peer review. Once the manuscript is accepted for publication or 
the submitter informs the receiving repository directly, the data will be publicly released 
(Fig. 1). At this point, the availability of the dataset, as well as basic metadata, will be 
disseminated through a public RSS feed (http://groups.google.com/group/proteomexchange/
feed/rss_v2_0_msgs.xml). The RSS feed includes a link to an XML message 
(ProteomeXchange XML), which is created by the receiving repository (Supplementary 
Notes, section 3), and made available from ProteomeCentral, the portal for all public 
ProteomeXchange datasets (http://proteomecentral.proteomexchange.org) (Supplementary 
Notes, section 2). Repositories such as PeptideAtlas or GPMDB as well as any interested 
end users can subscribe to this RSS feed and trigger actions, including incorporation of the 
data into local resources, re-processing or biological analysis. This reprocessing is already 
occurring in practice. For example, two ProteomeXchange datasets (PXD000134 and 
PXD000157) have been used in the latest build of the human proteome in PeptideAtlas, and 
PXD000013 (ref. 12) was reprocessed and nominated as technical dataset of the year 2012 
by GPMDB (http://www.thegpm.org/dsotw_2012.html - 201210071).
ProteomeXchange started to accept regular submissions in June 2012. By the beginning of 
August 2013, 373 ProteomeXchange datasets have been submitted (consisting of 341 
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tandem MS and 32 SRM datasets, Fig. 2), a total of ~25 TB of data. The largest submission 
so far (currently still private) comprised 5 TB of data. For a current list of the publicly 
available datasets, see http://proteomecentral.proteomexchange.org/.
In summary, ProteomeXchange provides an infrastructure for efficient and reliable public 
dissemination of proteomics data, supporting crucial validation, analysis and reuse. By 
providing and linking different interpretations of the data we aim to maximise dataset 
visibility as well as their potential benefit to different communities. Citability and 
traceability are addressed through the assignment of DOIs and a common identifier space. 
The consortium is open to the participation of additional resources (Supplementary Notes, 
Section 9). Although all repositories depend on continuous funding for continuous 
operation, the ProteomeXchange core repositories PRIDE and PeptideAtlas are well 
established, with first publications in 2005 (ref. 7,8), and have strong institutional backing 
(Supplementary Notes, section 8), ensuring that the data will remain reliably available for 
the foreseeable future. We are confident that the ProteomeXchange infrastructure will 
support the growing trend towards public availability of proteomics data, maximising its 
benefit to the scientific community through increased ease of access, greater ability to re-
assess interpretations and extract further biological insight, and greater citation rates for the 
submitters.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Representation of the ProteomeXchange workflow for MS/MS and SRM data. *Raw data 
represents mass spectrometer output files.
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Summary of the main metrics of ProteomeXchange submissions (by August 2013). The 
number of data sets is indicated for submission type, data access status and for the top 
species and countries represented.
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